Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
309.1 USD | +0.54% | +3.13% | +7.49% |
May. 28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
May. 28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.49% | 165B | |
+42.27% | 748B | |
+33.99% | 598B | |
-5.93% | 356B | |
+18.38% | 325B | |
+4.78% | 283B | |
+17.40% | 245B | |
+9.05% | 211B | |
-4.34% | 209B | |
+2.69% | 166B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen Wins Irish Court Approval to Acquire Horizon Therapeutics